RobertMarkFoxMD

Cardiology • Hollywood, FL

Physician

Join to view full profile

Are you Dr. Fox?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 32 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
2711 S Ocean Dr Unit 904
Hollywood, FL 33019
Phone+1 305-733-6101
Is this information wrong?

Summary

Dr. Robert Fox, MD is a cardiologist in Hollywood, Florida. He is currently licensed to practice medicine in Florida.

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cardiovascular Disease, 1982 - 1984
Temple University HospitalResidency, Internal Medicine, 1979 - 1982
Drexel University College of MedicineClass of 1979

Certifications & Licensure

FL State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi, P. F.,William, B. M.,Silva Rondon, C. H.,Fu, P.,Cooper, B. W.,Campagnaro, E. L.,Gerson, S. L.,Reese-Koc, J.,Fox, R.,Creger, R. J.,de Lima, M.,Lazarus, H. M.> ;Biol. Blood Marrow Transplant.. 2015 Jun 19
Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs, M. R.,Good, C. E.,Fox, R. M.,Roman, K. P.,Lazarus, H. M.> ;Transfusion. 2013 Mar 5
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an e...
> ;Biol Blood Marrow Transplant. 2005 Jan
Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients.
Creger RJ, Weeman KE, Jacobs MR, Morrissey A, Parker P, Fox RM, Lazarus HM> ;J. Clin. Microbiol.. 1998-01-01
Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation.
Espinosa MT, Fox R, Creger RJ, Lazarus HM> ;Transfusion. 1996-09-01
Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients.
Lazarus HM, Creger RJ, Gucalp R, Fox RM, Ciobanu N, Carlisle PS, Cooper BW, Jacobs MR> ;Int. J. Antimicrob. Agents. 1996-07-01
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruicksha...> ;Ann. Intern. Med.. 1994-10-01
Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG-CSF).
Campbell LJ, Maher DW, Tay DL, Boyd AW, Rockman S, McGrath K, Fox RM, Morstyn G> ;Br. J. Haematol.. 1992-03-01
29 citations
Relation between electrocardiographic and scintigraphic location of myocardial ischemia during exercise in one-vessel coronary artery disease
Robert M. Fox, A-Hamid Hakki, Abdulmassih S. Iskandrian, Jacqueline Hackney> ;The American Journal of Cardiology. 1984 Jun 1
Poly(A)+RNA as a possible target for deoxyadenosine induced G1/G0 lymphotoxicity.
Kefford RF, Fox RM, McCairns E, Fahey D, Muscat GE, Rowe PB> ;Adv. Exp. Med. Biol.. 1984-01-01
Flow cytometric analysis of adenosine analogue lymphocytotoxicity.
Kefford RF, Taylor IW, Fox RM> ;Cancer Res.. 1983-11-01
Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
Kefford RF, Fox RM, McCairns E, Fahey D, Muscat GE, Rowe PB> ;Cancer Res.. 1983-05-01
Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
Kefford RF, Fox RM> ;Cancer Chemother. Pharmacol.. 1983-01-01
S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes.
Kefford RF, Helmer MA, Fox RM> ;Cancer Res.. 1982-09-01
Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
Kefford RF, Fox RM> ;Br. J. Haematol.. 1982-04-01
Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
Kefford RF, Fox RM> ;Cancer Res.. 1982-01-01
Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.
Reddel RR, Kefford RF, Grant JM, Coates AS, Fox RM, Tattersall MH> ;Cancer Treat Rep. 1982-01-01
G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
Fox RM, Kefford RF, Tripp EH, Taylor IW> ;Cancer Res.. 1981-12-01
Causes of deaths in an oncology unit.
Kefford RF, Cooney NJ, Woods RL, Fox RM, Tattersall MH> ;Eur J Cancer Clin Oncol. 1981-10-01
Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomized study.
Kefford RF, Woods RL, Fox RM, Tatterall MH> ;Med. J. Aust.. 1980-10-18
Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplanta...
Hamza, N. S., Lisgaris, M., Yadavalli, G., Nadeau, L., Fox, R., Fu, P., Lazarus, H. M., Koc, O. N., Salata, R. A., Laughlin, M. J.> ;Br J Haematol. 2004 Feb
Academic health sciences centres laid bare.
Lozon, J. C., Fox, R. M.> ;Healthc Pap. 2002
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren, W. J., Fanning, L. R., Meyerson, H. J., Fu, P., Lazarus, H. M., Cooper, B. W., Tse, W. W., Kindwall-Keller, T. L., Jaroscak, J., Finney, M. R., Fox, R. ...> ;Br J Haematol. 2007 Nov
Join now to see all